SCANORTO A/S: Financial statements 2022
CVR: 12687648
Source: annual report 2022, Danish Business Authority
01/01/2022 – 31/12/2022
SCANORTO A/S (CVR 12687648) has filed annual accounts for 2022. In 2022, the company reported a gross profit of DKK 14,692,839 and a net result of DKK 860,799 compared with DKK 532,464 the year before. That is an increase of 15.3% compared with the year before. Equity in the 2022 report amounted to DKK 7,922,388. The solvency ratio was 41.8%. The company had 13 employees in the financial year.
- Gross Profit
- DKK 14,692,839
- Profit/Loss
- DKK 860,799
- Equity
- DKK 7,922,388
- Total Assets
- DKK 18,950,920
- Employees
- 13
Development
| Year | Revenue | Gross Profit | Profit/Loss | Equity | Employees |
|---|---|---|---|---|---|
| 2022 | - | 14.7 mio. | 861 t. | 7.9 mio. | 13 |
| 2021 | - | 12.7 mio. | 532 t. | 7.1 mio. | 13 |
| 2020 | - | 6.7 mio. | 733 t. | 6.5 mio. | 10 |
| 2019 | - | 6.4 mio. | 563 t. | 5.8 mio. | 10 |
| 2018 | - | 8.2 mio. | 1.1 mio. | 5.2 mio. | 10 |
Official annual report
Keep an eye on SCANORTO A/S
Get notified instantly about new financial statements, ownership changes, management changes and status changes.
Set up monitoringEvents in 2022
As of November 1, 2022, Filipa Alexandra Pinto De Almeida has joined the board of directors of SCANORTO A/S.
SCANORTO A/S has published its annual report for 2021. Gross profit came to DKK 12,741,359, and the net result was DKK 532,464.
As of August 8, 2022, Torben Nielsen has joined the board of directors of SCANORTO A/S.
As of August 8, 2022, Xavier Cherbavaz has left the board of directors of SCANORTO A/S.
About SCANORTO A/S
SCANORTO A/S is a Danish company of the type Aktieselskab based in Kgs. Lyngby, founded in 1989. The company is registered under the industry Engroshandel med læge- og hospitalsartikler. The company was previously named LASSE LAGER HOLDING ApS and ASX 14746 ApS. The management consists of Karel Rajchert. The board consists of Karel Budka (chair), Filipa Alexandra Pinto De Almeida and Karel Rajchert. The company is owned by NOBEL BIOCARE DANMARK A/S. The company has 12 employees (2026). In 2025, the company reported a gross profit of DKK 12,395,453 and a net result of DKK 1,917,702 compared with DKK 1,654,974 the year before. Equity in the 2025 report amounted to DKK 12,950,705.